Institute For Wealth Management, Llc. Gilead Sciences, Inc. Transaction History
Institute For Wealth Management, Llc.
- $788 Million
- Q4 2024
A detailed history of Institute For Wealth Management, Llc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Institute For Wealth Management, Llc. holds 7,357 shares of GILD stock, worth $808,902. This represents 0.09% of its overall portfolio holdings.
Number of Shares
7,357
Previous 7,457
1.34%
Holding current value
$808,902
Previous $625,000
8.64%
% of portfolio
0.09%
Previous 0.08%
Shares
29 transactions
Others Institutions Holding GILD
# of Institutions
2,090Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.7 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.88 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.64 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.37 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...